To test this hypothesis, we combined chemogenetic approaches with in vivo pharmacological manipulations (nor-BNI, a long-lasting KOR antagonist, 10 mg/kg) and assessed anxiety-like behaviors and morphine CPP (Figure 5A). This evidence concerns the gene OPRK1 and Anxiety.